Elevated CRP levels were associated with higher CD24/CD11b levels in the PBLs of healthy participants, suggesting that predictors of CD24/CD11b levels among healthy subjects may assist in further development and optimization of the CD24/CD11b biomarker to serve as a cancer screening test for the early detection of cancer among the healthy population. This evidence concerns the gene CRP and cancer.